122 related articles for article (PubMed ID: 8353141)
41. [Gastrointestinal cancer].
Takahashi Y
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558
[TBL] [Abstract][Full Text] [Related]
42. Prognostic and predictive molecular markers in colorectal carcinoma.
Bendardaf R; Lamlum H; Pyrhönen S
Anticancer Res; 2004; 24(4):2519-30. PubMed ID: 15330208
[TBL] [Abstract][Full Text] [Related]
43. Circulating microRNAs in cancer: diagnostic and prognostic significance.
Zhou L; Zhao YP; Liu WJ; Dong J; Chen WY; Zhang TP; Chen G; Shu H
Expert Rev Anticancer Ther; 2012 Feb; 12(2):283-8. PubMed ID: 22316375
[TBL] [Abstract][Full Text] [Related]
44. Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.
Jung K; Fleischhacker M; Rabien A
Clin Chim Acta; 2010 Nov; 411(21-22):1611-24. PubMed ID: 20688053
[TBL] [Abstract][Full Text] [Related]
45. [Tumor markers--serologic parameters for monitoring and therapeutic control of cancer patients].
Birkmayer J
Wien Med Wochenschr; 1988 Jun; 138(11-12):276-8. PubMed ID: 3176507
[TBL] [Abstract][Full Text] [Related]
46. [Expression of oncogene products and tumor markers in human cancers].
Kuzumaki N
Tanpakushitsu Kakusan Koso; 1987 Dec; 32(13):1572-6. PubMed ID: 3444892
[No Abstract] [Full Text] [Related]
47. [Tumor markers in the diagnosis of solid tumors].
Koch OM
Internist (Berl); 1992 Aug; 33(8):W79-86. PubMed ID: 1526714
[No Abstract] [Full Text] [Related]
48. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.
Chan KC; Lo YM
Br J Cancer; 2007 Mar; 96(5):681-5. PubMed ID: 17311021
[TBL] [Abstract][Full Text] [Related]
49. [Tumor markers: theory or reality?].
Molina R; Filella X; Ballesta AM
Med Clin (Barc); 1994 Feb; 102(5):189-95. PubMed ID: 8127170
[No Abstract] [Full Text] [Related]
50. [Tumor markers].
Sirotteau JC
Soins; 1990 Feb; (533):33-5. PubMed ID: 2321057
[No Abstract] [Full Text] [Related]
51. [Circulating tumor markers].
Pichon MF; Pecking A
Pathol Biol (Paris); 1993 Jan; 41(1):35-6. PubMed ID: 8316461
[No Abstract] [Full Text] [Related]
52. ICRmax: an optimized approach to detect tumor-specific interchromosomal rearrangements for clinical application.
Donnard ER; Carpinetti PA; Navarro FC; Perez RO; Habr-Gama A; Parmigiani RB; Camargo AA; Galante PA
Genomics; 2015 May; 105(5-6):265-72. PubMed ID: 25666663
[TBL] [Abstract][Full Text] [Related]
53. [Molecular changes in lipids in the early diagnosis of cancer].
Arias Vallejo E
Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):725. PubMed ID: 3438540
[No Abstract] [Full Text] [Related]
54. "Clinical and laboratorial remarks in the measurement of some tumor markers".
Giuliani F; Neri G; Bertolo M; Binetti L; Rossi C
J Nucl Med Allied Sci; 1990; 34(4 Suppl):281-4. PubMed ID: 2092134
[No Abstract] [Full Text] [Related]
55. [Human cancer and oncogene--application to clinical diagnosis].
Ueda N
Rinsho Byori; 1988 Jan; 36(1):47-55. PubMed ID: 3285052
[No Abstract] [Full Text] [Related]
56. Tumor markers and chemotherapy.
Francioni S; Pastore M; Castellaro E
J Nucl Med Allied Sci; 1990; 34(4 Suppl):251-9. PubMed ID: 2092128
[No Abstract] [Full Text] [Related]
57. [The use of immunological methods in the diagnosis of neoplastic diseases (a review of the literature)].
Lytsar' BN; Skvortsov SV; Ivlev AS
Voen Med Zh; 1992 Oct; (10):41-3. PubMed ID: 1481405
[No Abstract] [Full Text] [Related]
58. [Biological markers of cancers].
Bellet D; Bidart JM; Bohuon C
Rev Infirm; 1989 Nov; 39(18):32-4. PubMed ID: 2617005
[No Abstract] [Full Text] [Related]
59. [Laboratory diagnosis of cancer].
Vela E
An Esp Pediatr; 1988 Sep; 29 Suppl 32():96-100. PubMed ID: 3247979
[No Abstract] [Full Text] [Related]
60. Oncogenes and the pathogenesis of human cancers: implications for cancer diagnosis and management.
Cline MJ
Br J Clin Pract Suppl; 1988 Mar; 62():2-4. PubMed ID: 3145010
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
